Skip to content
PICO Portalanswers from OpenAlex

One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases

PaperCitations, authors & open-access status

One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases is a paper indexed in PICO Portal from OpenAlex.

How many citations does One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases have?

PICO Portalcitation count

One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases has 32 citations in the OpenAlex counts PICO Portal stores.

When was One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases published?

PICO Portalyear

One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases has 2020 year in the PICO Portal index.

What is the open-access status of One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases?

PICO Portaloa status

One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases has green oa status in the PICO Portal index.

What is the DOI of One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases?

PICO Portaldoi

The DOI for One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases is on the source record.

What is the PMID of One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases?

PICO Portalpmid

The PMID for One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases is on the source record.

What is the OpenAlex record for One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases?

PICO Portalopenalex

The OpenAlex for One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial